| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 04/06/1993 | US5200198 Medicament and its production and use in the treatment of pain, inflammation and fever in man and animals |
| 04/06/1993 | US5200197 Contraceptive pill |
| 04/06/1993 | US5200196 Improvement in pulsed drug therapy |
| 04/06/1993 | US5200195 Reducing stickiness of a dosage for to biological tissue in fluid environment of use |
| 04/06/1993 | US5200194 Oral osmotic device |
| 04/06/1993 | US5200193 Pharmaceutical sustained release matrix and process |
| 04/06/1993 | US5200192 Containing polyoxyalkylene glycol and polyoxyethylene glycol ester component |
| 04/06/1993 | US5200191 Encapsulating a fill in a shell, drying and heating again in a humid atmosphere to remove dimples and bubbles from shell |
| 04/06/1993 | US5200190 Estradiol dissolved in adhesive base: copolymer of 2-ethylhexyl acrylate and N-vinyl-2-pyrrolidone; flexible tape backing; impermeable to active ingredient |
| 04/06/1993 | US5200184 Deacylation using hydrolase enzyme |
| 04/06/1993 | US5200182 Antiviral or antibacterial composition and method of use |
| 04/06/1993 | US5200180 Mixture of calcium salt an dpolysacchride which form a gel |
| 04/06/1993 | CA1315778C Polyhydroxylated and highly fluorinated compounds, their preparation and their use as surfactants |
| 04/06/1993 | CA1315692C Pharmaceutical compositions for topical application with systemic action |
| 04/06/1993 | CA1315687C Dosage form for dispensing drug for human therapy |
| 04/06/1993 | CA1315684C Anti-retroviral agents and delivery system for the same |
| 04/06/1993 | CA1315682C Injection containing 3-benzoyloxy-1,3,5(10)-estratriene -17-¬4- p-(bis(2-chloroethyl)amino)phenyl -butanoyloxy| acetate as an active |
| 04/06/1993 | CA1315681C Tablet for use in the treatment of progesterone deficiency |
| 04/06/1993 | CA1315680C Sustained-release multi-granule tablet |
| 04/06/1993 | CA1315679C Rapidly dissoluble medicinal dosage unit and method of manufacture |
| 04/06/1993 | CA1315678C Alpha-tocopherol based vesicles |
| 04/06/1993 | CA1315628C System for delivering drug with enhanced bioacceptability |
| 04/05/1993 | CA2079642A1 Medicament |
| 04/04/1993 | CA2079701A1 Reservoir-system for sustained diffusion of an active principle |
| 04/03/1993 | CA2079658A1 Dry eye treatment process and solution |
| 04/03/1993 | CA2078388A1 Biocompatible emulsion particles |
| 04/02/1993 | CA2079541A1 Injectable extended release formulations and methods |
| 04/02/1993 | CA2079420A1 Pharmaceutical composition containing felbinac |
| 04/02/1993 | CA2076574A1 Extended-life drug filled patch |
| 04/01/1993 | WO1993006185A1 Propellant for aerosols and dosing aerosols |
| 04/01/1993 | WO1993006116A1 Glial derived neurotrophic factor |
| 04/01/1993 | WO1993005843A1 Dual rate agent delivery device |
| 04/01/1993 | WO1993005815A1 Synthetic transfection vectors |
| 04/01/1993 | WO1993005805A1 Emulsion containing parathyroid hormone for pernasal administration |
| 04/01/1993 | WO1993005799A1 Lyophilized stable pharmaceutical compositions containing a granulocyte macrophage colony stimulating factor |
| 04/01/1993 | WO1993005797A1 Compositions comprising a bactericidal/permeability increasing protein and a lipid carrier, methods of making same, and uses thereof |
| 04/01/1993 | WO1993005794A1 Preservative for pharmaceutical products |
| 04/01/1993 | WO1993005787A1 Method of administering dipalmitoylphosphatidylcholine dispersions |
| 04/01/1993 | WO1993005785A1 Combination pharmaceutical preparations containing a non-steroidal anti-inflammatory agent and nocloprost |
| 04/01/1993 | WO1993005782A1 Sparfloxacine salts and solutions containing same |
| 04/01/1993 | WO1993005777A1 Transocular preparation |
| 04/01/1993 | WO1993005776A1 Liquid tolnaftate preparation |
| 04/01/1993 | WO1993005771A1 Long-acting preparation |
| 04/01/1993 | WO1993005770A1 Long-acting preparation |
| 04/01/1993 | WO1993005769A1 Controlled release pharmaceutical preparations |
| 04/01/1993 | WO1993005768A1 Medication vehicles made of solid lipid particles (solid lipid nanospheres - sln) |
| 04/01/1993 | WO1993005767A1 Blended lipid vesicles |
| 04/01/1993 | WO1993005766A1 Method of preparing liposomes |
| 04/01/1993 | WO1993005765A1 Pressurised aerosol compositions |
| 04/01/1993 | WO1993005762A1 Utilization in cosmetic or topical applications of an aqueous dispersion based on organopolysiloxanes and a crosslinked copolymer of acrylamide/neutralized 2-acrylamido 2-methylpropane sulfonic acid |
| 04/01/1993 | WO1993005753A1 Composition providing a lasting cosmetic and/or pharmaceutical treatment of the upper epidermal layers by topical application on the skin |
| 04/01/1993 | WO1993005727A1 Veterinary transdermal active agent delivery device |
| 04/01/1993 | WO1993005680A1 Polymeric particles for dental applications |
| 04/01/1993 | WO1993001286A3 Localized oligonucleotide therapy |
| 04/01/1993 | DE4220123A1 Pharmazeutische praeparate Pharmaceutical products |
| 04/01/1993 | DE4132345A1 Medicament compsns. for intravenous admin. of lytic agents - used for treatment of tumours, auto-immune disorders, multiple sclerosis, etc. |
| 04/01/1993 | DE4131878A1 Verfahren zur herstellung von liposomen A process for the preparation of liposomes |
| 04/01/1993 | CA2119444A1 Preservative for pharmaceutical products |
| 04/01/1993 | CA2119270A1 Sparfloxacine salts and solutions containing them |
| 04/01/1993 | CA2119233A1 Transocular pharmaceutical preparation |
| 04/01/1993 | CA2119158A1 Controlled release pharmaceutical preparations |
| 03/31/1993 | EP0534916A1 The use of liposomal formulations containing papaverine for the treatment of male impotence |
| 03/31/1993 | EP0534860A1 Injectable stabilized solutions containing sparfloxacin or its salts |
| 03/31/1993 | EP0534731A1 Pressurised aerosol compositions |
| 03/31/1993 | EP0534618A2 Peptides for inducing cytotoxic T lymphocyte responses to hepatitis B virus |
| 03/31/1993 | EP0534445A1 Process for the preparation of a medicament for oral or topical administration in the treatment of leishmaniasis |
| 03/31/1993 | EP0534401A1 Implantable medical device |
| 03/31/1993 | EP0534310A1 Combination containing growth factors and polyelectrolytes |
| 03/31/1993 | EP0533938A1 Composition for rectal administration of difficultly absorbable peptide |
| 03/31/1993 | EP0533886A1 Preparation of diagnostic agents |
| 03/31/1993 | EP0533834A1 Intercellular adhesion mediators |
| 03/31/1993 | EP0533820A1 Pharmaceutical preparation. |
| 03/31/1993 | EP0533809A1 Polyurethane-biopolymer composite. |
| 03/31/1993 | EP0533799A1 Compositions and methods for the controlled release of soluble active substances. |
| 03/31/1993 | EP0533776A1 Polymeric films for forming capsule shells |
| 03/31/1993 | EP0533763A1 Fractionated agaroid compositions, their preparation, and use |
| 03/31/1993 | EP0533690A1 Phospholipid-coated microcrystals: injectable formulations of water-insoluble drugs |
| 03/31/1993 | EP0451182B1 Pharmaceutical formulations |
| 03/31/1993 | EP0436650B1 Hydrated lipidic lamellar phases or liposomes based on ecdysteroids |
| 03/31/1993 | EP0295248B1 Liposome preparation and antibiotic |
| 03/31/1993 | EP0265514B1 Medicaments for inhibiting skin wrinkling |
| 03/31/1993 | CN1070401A Production of beta-form thiamine hydrochloride crystals |
| 03/31/1993 | CN1070344A Composition for sustained and controlled release of medicamentous substances and process for preparing same |
| 03/31/1993 | CN1070341A Process for extracting effective component of xizang oriental wormwood, equipment and its tablet preparation method |
| 03/31/1993 | CN1070338A Manufacturing and using method of plaster for giving up smoking |
| 03/31/1993 | CN1070337A Ointments and ointment preparation |
| 03/31/1993 | CN1070323A Sustained-release matrices for dental application |
| 03/31/1993 | CA2079255A1 Long acting injectable formulations containing hydrogenated castor oil |
| 03/30/1993 | US5198470 Lipid compounds derived from sphingosines, process for preparing these and their applications, in particular in cosmetics and in the pharmacy of skin conditions |
| 03/30/1993 | US5198422 Complex With Aromatic Aldehyde, Sustained Release |
| 03/30/1993 | US5198229 Self-retaining gastrointestinal delivery device |
| 03/30/1993 | US5198228 Sodium carboxymethyl starch as both binder and disintegrating agent |
| 03/30/1993 | US5198227 Dual subcoated simulated capsule medicament |
| 03/30/1993 | US5198226 Sustained release |
| 03/30/1993 | US5198225 Skin disorders or wound healing agents |
| 03/30/1993 | US5198224 Polypeptide thin film |
| 03/30/1993 | US5198223 Estrogen/Progesterone, Skin Permeation Enhancer |
| 03/30/1993 | US5198222 Time release bolus |
| 03/30/1993 | US5198221 An inhalation composition containing medocromil sodium for obstructive airway disease |
| 03/30/1993 | US5198220 Drug delivery, polylactide/glycolide |